Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Mitsui Gains Interest in Shenzhen Main Luck Pharma

publication date: Apr 27, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Mitsui & Co., Ltd., a Japanese conglomerate with an interest in medical and healthcare, Japan, obtained a 34.2% stake in a China JV, Shenzhen Main Luck Pharmaceuticals. Main Luck is China’s second largest producer of chemotherapy drugs. Mitsui expects to export cancer drugs from Main Luck for sale globally and use the sales network developed by Main Luck to distribute its own drugs in China. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...